Abstract
A corrective method for the treatment of acute obstructive bronchitis is proposed, including T-activin in the complex therapy of children with acute obstructive bronchitis. In order to correct the immunological parameters, patients with ARD were prescribed T-activin subcutaneously at the rate of 2 μg / kg of body weight daily for 5 days and the sixth injection a week after injections. Clinically, all children who received T-activin showed positive dynamics with an increase in the effectiveness of treatment, which contributed to the normalization of indicators of the immune status of patients and prevented the development of relapses of the disease
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
